Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia is linked to a higher risk of coronary heart disease due to certain genetic factors and high homocysteine levels.

Men with early hair loss may have higher health risks similar to women with PCOS.

Low vitamin D levels may contribute to female pattern hair loss.

Certain inflammatory molecules and leptin may contribute to hair loss in cicatricial alopecia.

Higher FABP4 levels may help diagnose androgenetic alopecia early.

Higher NLR, PLR, and MPV may help diagnose androgenetic alopecia.

Young men with early hair loss and high SAA3 levels are at higher risk for heart disease.

Androgen-producing ovarian tumors can cause male-pattern hair loss in women.

Higher homocysteine levels may predict hair loss severity.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

Finasteride reduces PSA levels by around 40-50% in BPH patients.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Dialysis patients benefit from water-soluble vitamins but need careful management to avoid risks.

The authors agree more research with proper control groups is needed to understand hair loss.

A child with a rare vitamin D-resistant condition improved with treatment.

The document concludes that the development of certain tumors is influenced by genetic background and that a specific gene modification can lead to tumor regression and reduced growth.

Elderly patients with CCCA were all African American with low vitamin D, but no iron or zinc deficiencies, and no hormonal imbalances compared to younger patients.

Skin symptoms like fragile skin and easy bruising can indicate Cushing's syndrome, which requires early diagnosis and treatment to prevent serious health issues.

The document concludes that managing PCOS involves lifestyle changes, medication, and monitoring for associated health risks.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.

A patient's skin eruption was caused by the cancer drug cyclophosphamide and improved after stopping the drug.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Topical antiandrogens might treat skin issues like hair growth, balding, and acne, but finding effective treatments without side effects is challenging.

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

Certain immune cells are more common on the top of the head and might help predict or treat common hair loss.